Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Encompass HealthEHC |
-$262M |
 |
Brookdale Senior LivingBKD |
-$1.4M |
 |
AmedisysAMED |
-$1.6M |
 |
Tenet HealthcareTHC |
-$348M |
 |
Nutex HealthNUTX |
$50M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| BUFFETT WARREN E | Oct 27, 2025 | Sell | 401,514 | $135.3558 | $54M |
| BUFFETT WARREN E | Jul 31, 2025 | Sell | 1,635,962 | $140.6052 | $230M |
| HEARTY JAMES O | Jul 23, 2025 | Sell | 2,351 | $150 | $350,000 |
| BUFFETT WARREN E | May 27, 2025 | Sell | 71,966 | $139.5581 | $10M |
| BUFFETT WARREN E | May 27, 2025 | Sell | 19,330 | $138.5916 | $2.7M |
| BUFFETT WARREN E | May 27, 2025 | Sell | 11,978 | $140.1794 | $1.7M |
| BUFFETT WARREN E | May 23, 2025 | Sell | 800 | $138.6 | $110,000 |
| BUFFETT WARREN E | May 23, 2025 | Sell | 36,094 | $138.1933 | $5M |
| BUFFETT WARREN E | May 23, 2025 | Sell | 27,172 | $137.2775 | $3.7M |
| BUFFETT WARREN E | May 22, 2025 | Sell | 31,404 | $138.9407 | $4.4M |
| BUFFETT WARREN E | May 22, 2025 | Sell | 1,256 | $139.8798 | $180,000 |
| BUFFETT WARREN E | May 8, 2025 | Sell | 1,145,938 | $147.108 | $169M |
| BUFFETT WARREN E | Feb 19, 2025 | Sell | 54,979 | $154.475 | $8.5M |
| BUFFETT WARREN E | Feb 19, 2025 | Sell | 65,482 | $153.605 | $10M |
| BUFFETT WARREN E | Feb 19, 2025 | Sell | 9,477 | $155.2467 | $1.5M |
| BUFFETT WARREN E | Feb 18, 2025 | Sell | 1,800 | $158.01 | $280,000 |
| BUFFETT WARREN E | Feb 18, 2025 | Sell | 200 | $156.11 | $31,000 |
| BUFFETT WARREN E | Feb 18, 2025 | Sell | 50,016 | $154.7245 | $7.7M |
| BUFFETT WARREN E | Feb 18, 2025 | Sell | 39,531 | $153.6862 | $6.1M |
| BUFFETT WARREN E | Feb 18, 2025 | Sell | 28,515 | $155.4057 | $4.4M |
| BUFFETT WARREN E | Feb 14, 2025 | Sell | 27,901 | $158.4113 | $4.4M |
| BUFFETT WARREN E | Feb 14, 2025 | Sell | 1,300 | $159.1583 | $210,000 |
| BUFFETT WARREN E | Feb 14, 2025 | Sell | 30,075 | $151.5989 | $4.6M |
| BUFFETT WARREN E | Feb 14, 2025 | Sell | 34,132 | $150.7799 | $5.1M |
| BUFFETT WARREN E | Feb 14, 2025 | Sell | 34,789 | $152.703 | $5.3M |
| BUFFETT WARREN E | Feb 14, 2025 | Sell | 65,483 | $157.7413 | $10M |
| BUFFETT WARREN E | Feb 14, 2025 | Sell | 66,208 | $156.6825 | $10M |
| BUFFETT WARREN E | Feb 14, 2025 | Sell | 70,460 | $155.5383 | $11M |
| BUFFETT WARREN E | Feb 14, 2025 | Sell | 77,665 | $153.6614 | $12M |
| BUFFETT WARREN E | Feb 14, 2025 | Sell | 91,987 | $154.7041 | $14M |
| BUFFETT WARREN E | Feb 11, 2025 | Sell | 203,091 | $156.011 | $32M |
| Rodriguez Javier | Sep 16, 2024 | Sell | 50,000 | $165.0503 | $8.3M |
| Rodriguez Javier | Sep 13, 2024 | Sell | 9,881 | $162.8501 | $1.6M |
| ACKERMAN JOEL | Aug 28, 2024 | Sell | 4,740 | $155.0179 | $730,000 |
| Rodriguez Javier | Aug 27, 2024 | Sell | 7,943 | $155.9346 | $1.2M |
| ACKERMAN JOEL | Aug 27, 2024 | Sell | 64,029 | $155.0639 | $9.9M |
| Rodriguez Javier | Aug 26, 2024 | Sell | 32,176 | $155.9331 | $5M |
| STAFFIERI MICHAEL DAVID | Aug 16, 2024 | Sell | 32,580 | $150.1652 | $4.9M |
| STAFFIERI MICHAEL DAVID | Aug 15, 2024 | Sell | 9,539 | $150.0289 | $1.4M |
| Waters Kathleen Alyce | Aug 13, 2024 | Sell | 7,857 | $146.2093 | $1.1M |
| DESOER BARBARA J | May 10, 2024 | Sell | 5,030 | $138.81 | $700,000 |
| Rodriguez Javier | Feb 27, 2024 | Sell | 7,397 | $126.8713 | $940,000 |
| Rodriguez Javier | Feb 26, 2024 | Sell | 67,603 | $126.1058 | $8.5M |
| STAFFIERI MICHAEL DAVID | Feb 21, 2024 | Sell | 29,488 | $119.8123 | $3.5M |
| Waters Kathleen Alyce | Feb 21, 2024 | Sell | 11,285 | $120.73 | $1.4M |
| HEARTY JAMES O | Feb 16, 2024 | Sell | 26,164 | $119.6403 | $3.1M |
FAQ - Insider Transactions
The most recent insider transaction for DaVita was conducted by BUFFETT WARREN E, who sold 401,514 shares on October 27, 2025 at a price of $135.36 per share.
BUFFETT WARREN E has sold the most DVA stock in the last 2 years, with a total value of $628M.
The total value of insider transactions for DaVita in the last 2 years is negative, amounting to -$681M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for DaVita have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
